Aeva Technologies, Inc. current report, 12 March 2021

Abrir documento

Aeva Technologies, Inc. Form 8-K Summary

Business context and reporting period

Filed for events beginning March 12, 2021, following InterPrivate Acquisition Corp.’s completion of its business combination with Legacy Aeva, Inc. The combined company changed its name to Aeva Technologies, Inc. and ceased to be a shell company. The report was signed on March 18, 2021.

Key financial and capital-market metrics

  • PIPE financing: 28,168,478 newly issued shares were sold for aggregate proceeds of approximately $320.0 million, at purchase prices of $10.00, $11.50, or $16.00 per share.
  • Trust account: Public shareholders redeemed 30,874 shares for approximately $310,829, or approximately $10.07 per share. Approximately $242.8 million remained in the trust account immediately before closing, subject to transaction expenses and general corporate uses.
  • Shares outstanding: 211,042,833 shares of common stock were outstanding after closing; there were no preferred shares outstanding.
  • Debt and liquidity: The filing does not provide a post-closing debt balance, revenue, profit, cash-flow, margin, or detailed liquidity forecast. Sponsor working-capital loans totaling $1.5 million were converted into 150,000 common shares and 75,000 private-placement warrants.
  • Financial statements: Audited Legacy Aeva financial statements for 2020 and 2019, management’s discussion and analysis, and unaudited pro forma combined financial information were filed as exhibits or incorporated by reference; detailed amounts are not presented in the supplied filing text.

Material changes versus the prior comparable period

  • The transaction converted InterPrivate from a special-purpose acquisition company into the operating public company Aeva Technologies, Inc.
  • Legacy Aeva common stock, including shares issued upon preferred-stock conversion, converted at an exchange ratio of approximately 9.08 shares of Aeva common stock for each Legacy Aeva share.
  • Aeva’s common stock and warrants began trading on the NYSE under AEVA and AEVAW, respectively, on March 15, 2021, subject to continued listing compliance.
  • The company adopted amended and restated organizational documents, established a classified seven-member board structure with two initial vacancies, and implemented the Aeva 2021 Incentive Award Plan.
  • Ownership was concentrated: Mina Rezk beneficially owned 23.5%, Soroush Salehian Dardashti 12.6%, Lux-affiliated entities 14.9%, Canaan XI 9.7%, and Sylebra-affiliated entities 8.6%, based on the filing’s ownership table.

Guidance, outlook, commentary, risks, and unusual items

  • The filing does not provide a clear financial guidance range or operating forecast. Management’s business description, risk factors, and financial discussion are incorporated from the proxy statement and exhibits.
  • Principal risks include failure to maintain NYSE listing, securities-price volatility, intense competition, inability to commercialize products or services, growth execution, employee retention, product liability and regulatory proceedings, intellectual-property protection, supplier and manufacturing constraints, COVID-19 effects, public-company costs, and the possibility that Aeva may never achieve or sustain profitability.
  • Marcum LLP’s prior audit report included a going-concern explanatory paragraph, noting substantial doubt about the company’s ability to continue as a going concern because cash and working capital at December 31, 2020 were insufficient to complete planned activities.
  • Deloitte & Touche LLP was selected as the independent registered public accounting firm for 2021, replacing Marcum. Marcum reported no accounting disagreements or reportable events and furnished a letter to the SEC regarding the change.
  • Transaction bonuses of $1.0 million each were awarded to Soroush Salehian Dardashti and Mina Rezk, and $100,000 to Saurabh Sinha.
  • Registration rights allow eligible holders to demand underwritten offerings generally exceeding $30 million. Lock-ups generally apply for 180 days to specified Legacy Aeva holders and for up to one year to specified Sponsor holdings, subject to stated exceptions and release conditions.

Important facts investors should verify

  • Review Exhibits 99.2–99.4 for Legacy Aeva’s audited revenue, losses, cash flows, margins, balance sheet, going-concern disclosures, and pro forma capitalization.
  • Reconcile the approximately $320.0 million PIPE proceeds and approximately $242.8 million trust-account balance to transaction expenses and the company’s actual post-closing cash balance.
  • Assess dilution from the 211.0 million shares outstanding, warrants, options, incentive awards, and registration rights.
  • Confirm NYSE listing compliance and the trading status and terms of AEVA and AEVAW.
  • Review lock-up expiration dates and potential selling pressure from major holders.
  • Evaluate the continuing implications of the prior going-concern disclosure and the company’s path to profitability and additional financing needs.